Authors
Xin Yu, Ruitong Zhang, Hongwei Zhu, Peixiang Lan, Xingxiao Zhang
Published in
Trends in pharmacological sciences. Nov 18, 2026. Epub Nov 18, 2026.
Abstract
Lysophosphatidylcholine (LPC) is a bioactive lysophospholipid and circulating metabolite that is increasingly recognized as an important regulator of immune responses and tissue homeostasis. However, its immunoregulatory effects are diverse and sometimes opposing across cell types and disease contexts, and the factors underlying this variability remain to be examined. Advances in structural biology, lipidomics, and lipid metabolism provide new insights into how LPC's molecular structure, its interactions with membrane proteins, and its metabolic fate shape its biological effects and contribute to disease processes. In this article, we review the mechanisms by which LPC regulates membrane proteins, the factors determining its immunoregulatory effects, and therapeutic strategies targeting LPC and its metabolic pathways.
PMID:
43052120
Bibliographic data and abstract were imported from PubMed on 19 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0